QTc Dynamics Following Cardioversion for Persistent Atrial Fibrillation

BackgroundCardioversion (CV) for atrial fibrillation (AF) is common. We aimed to assess changes in QTc over time following electrical CV (ECV) for persistent AF, and to compare the benefit of using continuous Holter monitoring vs. conventional follow-up by ECG. MethodsProspective observational cohort study. We comprised 90 patients admitted to our center for elective ECV due to persistent AF who were prospectively enrolled from July 2017 to August 2018. All patients underwent 7-days Holter started prior to ECV. Baseline QTc was defined as median QTc during 1 h post ECV. The primary endpoint was QTc prolongation defined as QTc >= 500 ms, or >= 10% increase (if baseline QTc was >480 ms). Conventional monitoring was defined as 2-h ECG post ECV. ResultsMean age was 67 +/- 11 years and 61% were male. Median baseline QTc was 452 ms (IQ range: 431-479 ms) as compared with a maximal median QTc of 474 ms (IQ range: 433-527 ms; p <0.001 for the change in QTc from baseline). Peak median QTc occurred 44 h post ECV. The primary endpoint was met in 3 patients (3%) using conventional monitoring, compared with 39 new patients (43%) using Holter (p <0.001 for comparison). The Holter monitoring was superior to conventional monitoring in detecting clinically significant QTc prolongation (OR = 13; p <0.001). ConclusionsECV of patients with persistent AF was associated with increased transient risk of QTc prolongation in nearly half of the patients. Peak median QTc occurs during end of second day following ECV and prolonged ECG monitoring provides superior detection of significant QTc prolongation compared with conventional monitoring.

Automated summary

This study evaluated the changes in QTc over time following electrical cardioversion (ECV) in patients with persistent atrial fibrillation (AF), and compared the effectiveness of continuous Holter monitoring and conventional ECG follow-up. The results showed that ECV was associated with an increased transient risk of QTc prolongation in nearly half of the patients, and Holter monitoring was superior to conventional monitoring in detecting clinically significant QTc prolongation.